Overview

Proof of Concept Study on Pitolisant Effect on Autism Spectrum Disorders in Children and Adolescents

Status:
ACTIVE_NOT_RECRUITING

Trial end date:
2025-11-01

Target enrollment:

Participant gender:

Summary

Proof of concept, multicenter, randomized, double-blind, placebo-controlled, parallel-group, study to investigate the effect, safety, tolerability and pharmacokinetics of pitolisant in male children and adolescents with Autism Spectrum Disorders.

Phase:

PHASE2

Details

Lead Sponsor:

Bioprojet

Treatments:

pitolisant